Ruti Aga's Six-Year Ban: A Forged Prescription Turned a Two-Year Case Into a Career's Death

A prescription slip. A clinic that never existed. A "doctor" who was a family member and held no medical registration. And one sentence in the Athletics Integrity Unit's statement on Thursday — that the slip was written on "an old prescription pad from a former workplace." Ethiopian marathoner Ruti Aga has been banned for six years, and the headlines led with the substance: methylprednisolone.

The paperwork in my folder tells a different story. The six years did not come from the drug. They came from the document built to justify the drug. Without that forged slip, this was a two-year case — and two years, argued with a genuine knee-injury record, could have been shorter still. The raw sheet had two stories; I followed the one with a receipt.

Aga is not a minor name. She won the 2026 Tokyo Marathon and finished second at three World Marathon Majors. That places her in what I call the 2:18–2:20 class: nowhere near the world record, but a genuine podium contender in any marathon on the calendar. She is 32. In March she won a half marathon in China, and the in-competition sample was collected there. The AIU statement dates her provisional suspension to 10 September, and the ban runs from the same date.

The source does not state the year. I record that gap, because sanction arithmetic without a date is incomplete arithmetic. The case was processed under the World Athletics Anti-Doping Rules, applying the 2026 WADA Code and the WADA Prohibited List. And that is exactly where the coverage went wrong.

Methylprednisolone is not an anabolic steroid. It is a glucocorticoid — class S9 on the WADA List — and it is prohibited in-competition only. Several reports filed it as a "prohibited steroid," which is technically false and places the case on the wrong shelf. A therapeutic injection into the knee out of competition is entirely legal. It becomes a violation only if residues are present during competition.

There is a second technical detail worth knowing. The testing window for a road race opens at 23:59 the day before the race, which means an injection given days earlier is still caught. Aga's legitimate defence was route, timing and documented medical necessity. Instead of walking that path, she chose to manufacture the record.

Look at the architecture of the sanction: two years for the presence violation, four for tampering, six in total. That arithmetic is itself a finding: the panel rejected the no-significant-fault mitigation that would otherwise have cut the presence sanction. Two years is the standard outcome for a Specified Substance found without proven intent. Four years is the Code's standard tampering sanction. The sum is not judicial leniency in reverse; it is straightforward addition.

Backdating to 10 September is not a discount. Time served under provisional suspension counts against the ban, so the athlete gains nothing in real terms. That is procedure, not relief.

Now the slip that decided everything. Three separate verifications, all three failed. First, the clinic named on the prescription did not exist. Second, the person who wrote it held no medical registration — he was a relative. Third, the clinic explicitly disowned the "old pad" he cited. Three independent checks, three rejections. A forged document is proof of a lie, and here it also consumed the one defence that might have been true.

The knee injury is real, and it is the causal entry point of the entire case. Chronic knee pathology is a known failure mode in high-mileage marathoners, and glucocorticoids are the cheapest, most available tool for it. What is missing from the file is a team physician. An athlete with a credentialed doctor either holds a TUE or observes the route-specific washout period. Neither happened here; a prescription was fabricated instead. This is not a filing error. It is a medical-governance failure.

My own experience says the damage is worst where there is no document at all. After the 2026 Gold Coast relay selection dispute, I began keeping a private archive of federation circulars and selection policies, because I learned then that rules live on paper and careers are decided in the margins of that paper. Aga's case is the same principle inverted: where no document existed, one was created, and the creation was the heaviest cost of all.

Here is what the reports leave out. What was the winning time in that Chinese half marathon? What were the splits? How deep was the field? The source offers nothing, so I will not write a single sentence about the performance. All that is known is that she won, which implies a Label-tier elite field with testing present. The rest is inference, and inference cannot occupy the seat reserved for results.

The scope of disqualification is also unstated. Standard AIU practice voids the result and prize money of the competition where the sample was collected, which makes the March win and its earnings very likely forfeit — but the statement does not confirm it. That is the difference between a document and an assumption, and I will not merge the two.

One asset survives: the 2026 Tokyo title. The violation is anchored to a later March race, and absent a finding of earlier use, results before that date are not automatically annulled. Given the depth of Ethiopian women's marathoning this is close to meaningless for national selection, but on the record it stands. The performance in this case is secondary; the disciplinary file is the story.

Now the angle the statements will not supply. Six years for a glucocorticoid with no proven endurance benefit is a striking outcome. It will be read two ways: as evidence of AIU rigour, and as a question about whether sanction severity is set by the nature of the offence or by the fragility of the paperwork. I will not dodge that question, but I will not invent an answer either. The truth is that the six years punish the lie, not the drug — and anyone debating proportionality has to concede there are two offences here, not one.

The second angle belongs to the media. Calling methylprednisolone a steroid is not a harmless word choice. It files Aga alongside anabolic-steroid cases, where the stories involve intent, concealment and organised doping. Her case involves a knee, an informal medical network and a foolish slip of paper. When we mislabel the substance class, we also misplace the sanction.

The third angle is the one that stings. The Chinese half-marathon circuit is a thick appearance-fee, low-risk income tier for East African marathoners between Majors. That same tier is now the AIU's most productive testing ground. The appearance-fee economy and the testing economy are colliding in the same races, and the outcomes are landing on the layer that ran with the thinnest supervision. That is not about Aga; it is about the system she raced inside.

One more thing belongs in the open. Silence in a file is also a finding. There is no statement from the Ethiopian federation. There is no mention of any investigation into an agent or management, though somebody suggested or accepted that prescription. The AIU statement names only the family member. An athlete does not forge a prescription alone; someone helps her forge it. The file does not name that second person, and that is its largest hole.

Line up enough of these cases by year and a pattern appears. The enforcement frontier has moved from detection to document verification. The East African road-racing cases where an initial substance violation is compounded by a fabricated explanation are no longer separate incidents; they are a family. Where medical support is informal, the pattern repeats. My expectation is that more will emerge from the same networks serving the same training clusters.

The path forward is narrow. A CAS appeal window, typically about 21 days from the reasoned decision, is open, and a document-based finding is hard to overturn — especially with three independent verifications failed. Six years from 10 September means a return at 38, if at all. Ethiopia's women's marathon depth barely accommodates a 32-year-old; a 38-year-old with a doping record is effectively unselectable. On paper this is a six-year ban; in effect it runs to the end of a career.

What I am left counting is a counterfactual. Had the slip never been written, does this end at two years, with an explanation about treating an injured knee? And if so, the question is not why Aga lied. It is how many athletes in that same training cluster are being treated right now without a doctor, without a record, without a TUE — and simply have not yet needed a prescription pad because nobody has knocked on the door with a sample bottle. Receipts that are never kept are eventually settled in the sanction.